1Kondo K,MuraseM,Kodera Y, et. al, Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology,1996,53(1):64 被引量：1
2Sasaki K,Hirata K,Denno R,et.al.Combination chemotherapy of continous infusion 5-fluorouracil and daily low-dose cisplatin in advanced gastrointestinal and lung adenocarcinoma. Gan To Kagaku Ryoho, 1997,24(8):959 被引量：1
3Anderson JS, Burris HA, Casper E, et al. Development of a new system for assessing clinical benefit for patients with advanced pancreatic cancer[J]. Proe Am Soc Clin Oncol, 1994, 12:461 -465. 被引量：1
4Sehantz SP, Harrison LB, Forastiere AA, et al. Cancer: principles and practice of oncology ( ed 5 ). Philadelphia [ M ]. Lippincett Raven, 1997.741. 被引量：1
5Likich JJ, Ahlgren JD, Phillips JA, et al. A prospective randomized comparison of continous infusion fluoraracil with a conventional bouls schedule in metastatic Colorectal carcinoma: a mid-atlantic oncology program study[J]. J Clin Oncol, 1989,7(8) :425. 被引量：1
6Shirasaka T, Shimamoto Y, Ohahimo H, et al. Metabolic basis of the synergistic antitamor activities 5-fluoroiracil and Cisplatin in rodent tumor models in vivo Cancer Chemother [ J ]. Pharmacol,1993, 32(3) :167. 被引量：1
7Kamano T, Mikami Y. Continous infusion of 5-fluoroiracil plus low close cisplatin in tumor-bearing mice [ J ]. Anticancer Drug1997, 8(6) :632. 被引量：1
8Forastiere AA, Newberg D, Taylor SG, et al. Phase Ⅱ evaluation of Taxol in advanced head and neck Cancer: AN Eastern Cooperation Oncology group trial[ J]. JNATL Cancer lnst Monogr 1993,15(1) :181. 被引量：1
9Givana M, Fausto C, Roberto D, et al. Vinorelbin continuous infusion 5-fluoroiracil and cisplatin in patients with inoperable head and neck carcinoma regime with a low toxcity profile[ M]. Pro AS-CO 2000. 1694. 被引量：1
2Blazick S, Rovensky J, Koska J, et,al. Effect of hyperthermic water bath on parameters of cellular immunity[ J]. Int J Clin Pharmacol Res,2000,20(1-2) :41-46. 被引量：1
